Latest News

Steps in Abstract Submission Process: 

• Submission: Abstracts must be submitted by January 14, 2026, at 4 pm ET.
• Formatting review: Abstracts not meeting the style criteria will not be accepted.
• Peer Review: Submissions will undergo peer review and be accepted or declined based on reviewer feedback.
• Acceptance: Authors will be informed of decisions by March 3, 2026. 
• Registration: All submitting authors must register for PPC 2026. Poster presenters must be registered by March 31, 2026.
• Poster PDF Submission: Accepted posters must be submitted as PDFs for the virtual platform by April 7, 2026.
• Conflict of Interest and Livestream Agreement: All authors (including non-presenting authors) must complete this required form. 

Poster Abstract Guidelines – Professional Practice Conference 2026 

Category 

Authors must select the category that best fits their abstract. Submissions will be reviewed according to the chosen category:

• Original Research: Includes pharmaceutical/basic science, clinical research, drug use evaluations, systematic reviews (with or without meta-analysis), pharmacoeconomic analyses, etc.
• Pharmacy Practice: Includes administration projects, health professional education, medication safety initiatives, and other practice-based initiatives. 
• Case Reports 

Abstract Style Requirements

Abstracts that do not adhere to the following rules will be rejected. 

Title 

• Must be brief and clearly indicate the focus of the presentation.
• Use title-style capitalization (capitalize the first letter of major words only; do not capitalize prepositions unless first in the title).
• Do not use abbreviations or include a period at the end. 
• Use numerals rather than writing out numbers. 

Authors

• List only authors who contributed to the preparation of the abstract and will appear in the publication in the Canadian Journal of Hospital Pharmacy. 
• List as Last name + initials (e.g., “Lee K, Patel L, Smith J”) under the title, using superscript numbers linked to affiliations. 
• List affiliations below authors, identifying departments/faculties first, followed by the institution, city, and two-letter provincial abbreviation. 
• For authors with multiple affiliations, separate superscript numbers with commas (no spaces). 
• For international affiliations, include the country name. 
• Do not include degrees, titles, or appointments. 
• Underline the presenting author’s name. 

Body and headings 

Organize the body of the abstract using the exact headings outlined below for the selected category. Use bold for paragraph headings, add a colon after paragraph headings, and capitalize the second word in a two-word heading, such as “Literature Review”. Please note that studies with multiple outcomes must be presented in the same poster. Do not report individual outcomes from the same study data in separate posters.

• Original Research:
  • Background: Briefly describe the rationale for the study  
  • Objective(s): State the main study objective(s)  
  • Methods: Include study design, methods, intervention, and statistical analysis  
  • Results: Summarize main findings 
  • Conclusion(s): State the main conclusion and interpretation supported by the data
• Case Reports: 
  • Background: Briefly describe the rationale for the case report  
  • Case Description: Provide details of the case to clearly outline the background and support the assessment of causality  
  • Assessment of Causality: Explain the association between the therapy and the observed outcome.  Where appropriate, a causality assessment tool should be used (e.g. Naranjo scale for adverse drug reactions).  
  • Literature Review: Briefly summarize existing, relevant literature relating to or surrounding the case   
  • Importance to Practitioners: Briefly describe implications/importance of the case report to pharmacy professionals 
• Pharmacy Practice:
  • Background: Briefly describe the rationale or need for the project 
  • Description: Outline the concept, service, role, or situation  
  • Action: Describe the steps taken to identify and resolve a problem(s), implement change, or develop and implement the new program  
  • Evaluation: Present evaluation process and results 
  • Implications: Highlight the importance and relevance to practice  

Abstract Formatting 

• Abstract body (not including title and authors) is limited to 300 words. This includes the required section headings as outlined above. Any abstract that exceeds the word count will be rejected.  
• Each table is equivalent to 30 words.  
• Each graphic is equivalent to 60 words.  
• Results or evaluation must be included in the abstract. Abstracts that state ‘results will be discussed’ will be rejected.  
• Do not indent the start of a paragraph.  
• Place abbreviations in parentheses after the full word or phrase upon first mention. Keep abbreviated terms to a minimum.  
• Use numerals to indicate numbers, except at the beginning of a sentence.  
• Use only generic names of drugs, material, devices, and equipment (or both generic and trade names where the use of a trade name is deemed necessary). 
• Do not include citations, reference numbers, or reference lists.

Submission instructions  

• Authors must submit TWO copies of their abstract:
  • Original copy for publication in the conference program
  • Blinded copy for peer review
    • Blinded copy Requirements:
      •  Remove all author names, affiliations, and identifying information.
      • Ensure the title and text do not reference the authors, program, or institution.
      • Clearly state the selected category and include a word count.

• Abstracts MUST be submitted electronically as a file in MS Word format
• The two MS Word files must be named according to the following convention:
  • Blinded copy: First three words of the title_Blinded 
  • Unblinded copy: First three words of the title_Submitter's last name_Unblinded

Only abstracts that meet these requirements for formatting and submission will be considered. 

Submission deadline: The deadline for abstract submissions is January 14, 2026 at 16:00 ET

View the abstracts from PPC 2025 here:

Sample Abstract: 

Original Research: